Ohcanbohtosat - Kris, Mark G.
- Čájehuvvo 1 - 20 / 167
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
-
4
Creating a Synthetic Clinical Trial: Comparative Effectiveness Analyses Using an Electronic Medical Record Dahkki Zauderer, Marjorie G., Grigorenko, Aleksandr, May, Paul, Kastango, Nicholas, Wagner, Isaac, Caroline, Aryeh, Kris, Mark G.
Almmustuhtton 2019Teaksta -
5
Making Checkpoint Inhibitors Part of Treatment for Patients with Locally Advanced Lung Cancers: The Time is Now Dahkki Kris, Mark G., Faivre-Finn, Corinne, Kordbacheh, Tiana, Chaft, Jamie, Luo, Jia, Tsao, Anne, Swisher, Stephen
Almmustuhtton 2020Teaksta -
6
Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib – implications for clinical... Dahkki Chaft, Jamie E., Oxnard, Geoffrey R., Sima, Camelia S., Kris, Mark G., Miller, Vincent A., Riely, Gregory J.
Almmustuhtton 2011Teaksta -
7
Phase II Study of Docetaxel and Vinorelbine as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancers Dahkki Chaft, Jamie E., Rekhtman, Natasha, Sima, Camelia S., Rusch, Valerie, Kris, Mark G., Zakowski, Maureen, Azzoli, Christopher G.
Almmustuhtton 2013Teaksta -
8
Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma Dahkki Mattar, Marissa S., Chang, Jason, Benayed, Ryma, Halpenny, Darragh, Powers, Astin, Kleiner, David, Drilon, Alexander, Kris, Mark G.
Almmustuhtton 2019Teaksta -
9
Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung Dahkki Chaft, Jamie E., Sima, Camelia S., Ginsberg, Michelle S., Huang, James, Kris, Mark G., Travis, William D., Azzoli, Christopher G.
Almmustuhtton 2012Teaksta -
10
Response to Erlotinib in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancers with a Squamous or Squamous-like Component Dahkki Paik, Paul K., Varghese, Anna M., Sima, Camelia S., Moreira, Andre L., Ladanyi, Marc, Kris, Mark G., Rekhtman, Natasha
Almmustuhtton 2012Teaksta -
11
A phase 1/2 trial of ruxolitinib and erlotinib in patients with EGFR-mutant lung adenocarcinomas with acquired resistance to erlotinib Dahkki Yu, Helena A., Perez, Leslie, Chang, Qing, Gao, Sizhi P., Kris, Mark G., Riely, Gregory J., Bromberg, Jacqueline
Almmustuhtton 2016Teaksta -
12
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment Dahkki Basch, Ethan, Deal, Allison M., Dueck, Amylou C., Scher, Howard I., Kris, Mark G., Hudis, Clifford, Schrag, Deborah
Almmustuhtton 2017Teaksta -
13
Lungs don’t forget: Comparison of the KRAS and EGFR mutation profile and survival of “collegiate smokers” and never smokers with advanced lung cancers Dahkki Varghese, Anna M., Sima, Camelia S., Chaft, Jamie E., Johnson, Melissa L., Riely, Gregory J., Ladanyi, Marc, Kris, Mark G.
Almmustuhtton 2013Teaksta -
14
Reflex testing of resected stage I-III lung adenocarcinomas for EGFR and KRAS mutation, report on initial experience and clinical utility at a single center Dahkki D’Angelo, Sandra P., Park, Bernard, Azzoli, Christopher G., Kris, Mark G., Rusch, Valerie, Ladanyi, Marc, Zakowski, Maureen F.
Almmustuhtton 2011Teaksta -
15
Association of KRAS and EGFR Mutations with Survival in Patients with Advanced Lung Adenocarcinomas Dahkki Johnson, Melissa L., Sima, Camelia S., Chaft, Jamie, Paik, Paul K., Pao, William, Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Almmustuhtton 2012Teaksta -
16
A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically-resected stage I-IIIA non-small cell lung cancers Dahkki Drilon, Alexander, Sugita, Hirofumi, Sima, Camelia S., Zauderer, Marjorie, Rudin, Charles M., Kris, Mark G., Rusch, Valerie W., Azzoli, Christopher G.
Almmustuhtton 2014Teaksta -
17
KRAS Mutation is a Significant Prognostic Factor in Early Stage Lung Adenocarcinoma Dahkki Kadota, Kyuichi, Sima, Camelia S., Arcila, Maria E., Hedvat, Cyrus, Kris, Mark G., Jones, David R., Adusumilli, Prasad S., Travis, William D.
Almmustuhtton 2016Teaksta -
18
Brief Report: Novel Germline Mutations in DNA Damage Repair in Patients with Malignant Pleural Mesotheliomas Dahkki Guo, Robin, DuBoff, Mariel, Jayakumaran, Gowtham, Kris, Mark G., Ladanyi, Marc, Robson, Mark E., Mandelker, Diana, Zauderer, Marjorie G.
Almmustuhtton 2019Teaksta -
19
Allele-specific role of ERBB2 in the oncogenic function of EGFR L861Q in EGFR-mutant lung cancers Dahkki Sato, Hiroki, Offin, Michael, Kubota, Daisuke, Yu, Helena A., Wilhelm, Clare, Toyooka, Shinichi, Somwar, Romel, Kris, Mark G., Ladanyi, Marc
Almmustuhtton 2020Teaksta -
20
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations Dahkki Paik, Paul K., Arcila, Maria E., Fara, Michael, Sima, Camelia S., Miller, Vincent A., Kris, Mark G., Ladanyi, Marc, Riely, Gregory J.
Almmustuhtton 2011Teaksta